The store will not work correctly when cookies are disabled.
2-ethyl-3-(2,4-dibromo-3-hydroxybenzoyl)benzofuran
ID: ALA4515081
PubChem CID: 155539625
Max Phase: Preclinical
Molecular Formula: C17H12Br2O3
Molecular Weight: 424.09
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CCc1oc2ccccc2c1C(=O)c1ccc(Br)c(O)c1Br
Standard InChI: InChI=1S/C17H12Br2O3/c1-2-12-14(9-5-3-4-6-13(9)22-12)16(20)10-7-8-11(18)17(21)15(10)19/h3-8,21H,2H2,1H3
Standard InChI Key: YRKLGGCBKIKQIQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
18.3606 -9.8186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3595 -10.6382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0675 -11.0471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7772 -10.6377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7744 -9.8150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0657 -9.4098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6528 -9.4102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6526 -8.5930 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.9452 -9.8190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2014 -9.4884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6548 -10.0958 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.8628 -10.6333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0632 -10.8006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8098 -11.5752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3550 -12.1833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1568 -12.0115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4065 -11.2370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0312 -8.6891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2539 -8.4370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0633 -8.5926 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
20.4805 -9.4038 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.4855 -11.0452 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
1 7 1 0
7 8 2 0
7 9 1 0
9 10 2 0
10 11 1 0
11 13 1 0
12 9 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
10 18 1 0
18 19 1 0
6 20 1 0
5 21 1 0
4 22 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 424.09 | Molecular Weight (Monoisotopic): 421.9153 | AlogP: 5.46 | #Rotatable Bonds: 3 |
Polar Surface Area: 50.44 | Molecular Species: ACID | HBA: 3 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 6.16 | CX Basic pKa: ┄ | CX LogP: 5.55 | CX LogD: 4.34 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.57 | Np Likeness Score: 0.22 |
References
1. Ohe T, Umezawa R, Kitagawara Y, Yasuda D, Takahashi K, Nakamura S, Abe A, Sekine S, Ito K, Okunushi K, Morio H, Furihata T, Anzai N, Mashino T.. (2018) Synthesis of novel benzbromarone derivatives designed to avoid metabolic activation., 28 (23-24): [PMID:30389287] [10.1016/j.bmcl.2018.10.023] |